1. Discovery of an Inhibitor for the TREK-1 Channel Targeting an Intermediate Transition State of Channel Gating
- Author
-
Yanxin Che, Fei Guo, Huaiyu Yang, Yang Li, Yuqin Ma, Jie Fu, Qiansen Zhang, Lianghe Mei, and Qichao Luo
- Subjects
Patch-Clamp Techniques ,Allosteric regulation ,Druggability ,CHO Cells ,Molecular Dynamics Simulation ,Ligands ,01 natural sciences ,03 medical and health sciences ,Cricetulus ,Potassium Channels, Tandem Pore Domain ,Drug Discovery ,Potassium Channel Blockers ,Animals ,Humans ,Patch clamp ,Ion channel ,030304 developmental biology ,0303 health sciences ,Transition (genetics) ,Chemistry ,State (functional analysis) ,Potassium channel ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Drug Design ,Biophysics ,Molecular Medicine ,Ion Channel Gating ,Allosteric Site ,Communication channel - Abstract
Modulators can be designed to stabilize the inactive and active states of ion channels, but whether intermediate (IM) states of channel gating are druggable remains underexplored. In this study, using molecular dynamics simulations of the TWIK-related potassium channel 1 (TREK-1) channel, a two-pore domain potassium channel, we captured an IM state during the transition from the down (inactive) state to the up (active-like) state. The IM state contained a druggable allosteric pocket that was not present in the down or up state. Drug design targeting the pocket led to the identification of the TKIM compound as an inhibitor of TREK-1. Using integrated methods, we verified that TKIM binds to the pocket of the IM state of TREK-1, which differs from the binding of common inhibitors, which bind to channels in the inactive state. Overall, this study identified an allosteric ligand-binding site and a new mechanistic inhibitor for TREK-1, suggesting that IM states of ion channels may be promising druggable targets for use in discovering allosteric modulators.
- Published
- 2020
- Full Text
- View/download PDF